Argent BioPharma (RGT), formerly MGC Pharmaceuticals, has sold the global commercialisation rights of its leading epilepsy drug, CannEpil, in order
In response to this growing exodus of promising biotech firms, the European Union has proposed a new Biotech Act, as part of ongoing efforts by the European Commission to strengthen the continent’s biotechnology and biomanufacturing sectors, which have struggled with fragmented rules and sluggish approval processes.
Florida Governor Ron Desantis and his wife are coming under increasing scrutiny over their apparent use of millions in public settlement funds to bankroll a critical anti-cannabis legalization campaign.
UK-listed medical cannabis producer Celadon Pharmaceuticals is struggling to emerge from its precarious financial position after months of turmoil.
Newly rebranded California-based cannabis operator Eaze raised $10 million to acquire select assets of Eaze Technologies, its predecessor company, to fund the reopening of 70 Eaze and Green Dragon locations across California, Colorado, Florida and Michigan.
California’s Department of Cannabis Control (DCC) has announced it has doubled funding for the Phase II round of its Local
We won’t spam you
